The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. - Wikidata - awgldk - TriplyDB

The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

http://www.wikidata.org/entity/Q37399283

about

Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic Cancer Dinosaurs and ancient civilizations: reflections on the treatment of cancer Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis Regulation of Metastasis by microRNAs in Ovarian Cancer Gender Differences in Adipocyte Metabolism and Liver Cancer Progression Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential Pea3 transcription factors and wnt1-induced mouse mammary neoplasia Upregulation of proapoptotic microRNA mir-125a after massive small bowel resection in rats.Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor α: implications for cancer therapeutics.Epigenetic regulation of cancer-associated genes in ovarian cancer.The interconnectedness of cancer cell signaling.ARID3B Directly Regulates Ovarian Cancer Promoting Genes.The roles of microRNAs in the regulation of tumor metastasis.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.Epithelial-mesenchymal transition in ovarian carcinoma A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.Diverse functions of miR-125 family in different cell contexts.Changes in cell shape are correlated with metastatic potential in murine and human osteosarcomas.MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1 Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Regulation of breast cancer and bone metastasis by microRNAs The War on Cancer rages on.Recent advances in the ARID family: focusing on roles in human cancer.A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia.MicroRNAs and their role in gynecological tumors.MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs.Role of epigenomics in ovarian and endometrial cancers.Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.Biogenesis, evolution and functional targets of microRNA-125a.A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations.

P2860

Q21129296-24F9328E-8059-497F-8382-16F694031D91 Q24628746-AC0803ED-5E88-4277-A4BF-85FB28A3F980 Q26745561-B7CAF513-C86D-452B-A211-265620BBC1AE Q26746952-C05548CD-43CF-4D51-BADF-CF106978014E Q26997006-4F1C8D6C-1D5C-410B-9DFA-3F7014426997 Q28078472-B0DA299E-F02F-4DBF-85D9-6004AADDB2A3 Q28084310-16D10523-30F8-41DC-8A00-164F35F049B0 Q33526975-9E64874B-3724-4ED1-BEE8-0D0EE377E6B4 Q33974830-2435B69B-DC68-4543-9BAC-30B1A7BB992C Q34328740-CD8BC544-31CA-4DC7-A681-2F35538DF3A1 Q34356351-CAAA77B3-3903-415B-964C-E31E3C56C55B Q34364547-9B700971-AAD0-4285-8F10-6ADB7D5502E2 Q34483574-30125E97-5196-4D2B-8F4E-2270F1BB5E65 Q34509860-8B7BE2D1-5675-48F7-84DF-A6B4A3ABDD66 Q34874813-4A6C6C0E-09B9-4FB5-9F2A-B9C03D250316 Q35669733-ACAF27FE-A2B1-4364-9D4D-C6C68A7DA859 Q35677352-46ABCEC5-19D2-46D1-AADA-FE55E964740E Q35816884-2532D147-2F1B-4A53-9BDD-6D40848D2BDF Q35837949-223F999D-D470-4474-901D-A1C1ACA7714C Q35961920-62C5266B-F0C0-4762-9A46-47FE1C9EFCC2 Q35971814-80C0C21E-A0D6-453F-98F6-A893F95A73B5 Q36129967-90227B92-D8EA-4055-B96C-7EEEDFC52D83 Q36143137-3484C3C5-3AC4-441E-A98F-A496E213D33D Q36413160-19E8A818-6A85-4BD7-982F-91BC594212D0 Q36594402-6191C609-8FFE-4163-B8A8-6E8713DB9413 Q36736913-CCCDD5EE-017F-437F-A32D-A37424B457FB Q36962391-CE85F11E-CE94-4AEB-BEAD-54AF2532BB6E Q36992190-AF234461-5109-4AA1-84F7-A9CBF8BFDB53 Q37259128-C18E85F6-F76C-43AD-8C8F-165475E82D62 Q37478602-363F8935-C656-4B54-87D5-E26DED9E6440 Q37601383-3067B0B1-8D8E-4266-9428-0909783EE9D5 Q37662204-6AECC4A6-3ACD-4257-8995-C6212A55A48B Q37722649-762FA9DC-D95C-4369-8575-CCA2CDA54029 Q37828424-227B7C55-C9AE-4A98-93D5-1E9B0DACD292 Q37961734-7075D46E-DCB2-42E1-B414-260DFCA54731 Q37991651-B705A331-4ADC-4B92-8E45-A0EC32A857FA Q38043263-950D05B8-1DDE-4732-86E4-5FC6A09C126A Q38115692-240FAD94-4DC8-46FD-9E9E-A79BAC03040B Q38334606-43D9D38E-B232-4316-A833-C50541FC6AA4 Q38342516-36EEE995-7DE5-4EE6-93A7-1C775FBC83B1

P2860

The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

http://www.wikidata.org/entity/Q37399283

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

The epidermal growth factor re ...... ology in ovarian cancer cells.

@en

The epidermal growth factor re ...... ology in ovarian cancer cells.

@nl

type

label

The epidermal growth factor re ...... ology in ovarian cancer cells.

@en

The epidermal growth factor re ...... ology in ovarian cancer cells.

@nl

prefLabel

The epidermal growth factor re ...... ology in ovarian cancer cells.

@en

The epidermal growth factor re ...... ology in ovarian cancer cells.

@nl

P1433

Q37399283-8BBA7A13-606E-454A-9B4D-FEA79EF1F534

P1476

Q37399283-179F4239-D174-4854-8894-A2878FD62867

P2093

Q37399283-03135BB6-77E6-4C93-810E-BE2ADE2BD8DF

Q37399283-479314A4-76AA-403C-B2DD-14B70A255D67

Q37399283-66C30BAD-E846-41F3-92CE-39E31E4C9EF9

P2860

Q37399283-167A86E8-CFE2-411E-B896-F052980338CA

Q37399283-1EF47CE7-42AA-4841-A120-B5A6B119B112

Q37399283-1FA8C0CA-2BB4-4B51-BCEC-FE0C030714C6

Q37399283-2114F08E-C801-45F0-8FA4-E63030DA444D

Q37399283-26CD1423-9CF1-4079-A375-BFCFE4E2AF8B

Q37399283-35ACE739-BD68-4E33-A618-165396DCCECE

Q37399283-3DE5EADA-D898-46A8-8AC9-12CF8E5DC0BC

Q37399283-66CC12BD-C3F3-4435-AAF9-B46F0BD000CB

Q37399283-7EA8BEA5-E1CE-45AC-A772-7C71A0F22A5A

Q37399283-8DCF7FE5-1399-4EA8-A3CD-0E9471078342

P304

Q37399283-D661AD6C-2EBD-4B81-99D2-1B5BABC2FB46

P31

Q37399283-31E1795F-A59E-4C9D-BE0B-C2A57257DC72

P356

Q37399283-EBC12DE2-4BE0-483A-8395-B662B2221C4E

P433

Q37399283-803AE62E-86CF-4FBD-B582-0A1B7A0F39A3

P478

Q37399283-BDD117D2-5E25-4611-BAD4-3829FC0ED6A4

P50

Q37399283-3D113CD4-135B-4A41-89C1-F97AFA2E22FA

P577

Q37399283-599B46F1-F3CD-4DDF-AF07-BBF2D3A799A2

P5875

Q37399283-93B0F1E2-B6CC-43DB-8367-C7EBB765F3C7

P698

Q37399283-486257DF-980A-4113-B439-E85E4E8C46D0

P921

Q37399283-EDDC3387-4214-4C83-BE13-C2C54ED5BD70

P932

Q37399283-612F9663-13B3-43A3-AF72-14CC9A955937

P356

P1433

P1476

The epidermal growth factor re ...... hology in ovarian cancer cells

@en

P2093

Jessica N Kruichak

http://www.w3.org/2001/XMLSchema#string

Karen D Cowden Dahl

http://www.w3.org/2001/XMLSchema#string

Laurie G Hudson

http://www.w3.org/2001/XMLSchema#string

P2860

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

MicroRNA signatures in human ovarian cancer

Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion

A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye

Molecular requirements for epithelial-mesenchymal transition during tumor progression

Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells.

Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.

PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.

Differential gene expression in ovarian carcinoma: identification of potential biomarkers

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

P304

1208-1215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.09942

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38060146

http://www.w3.org/2001/XMLSchema#string

P698

19881956

http://www.w3.org/2001/XMLSchema#string

P921

P932

2767222

http://www.w3.org/2001/XMLSchema#string